| Cancer-associated mucins: role in immune modulation and metastasis R Bhatia, SK Gautam, A Cannon, C Thompson, BR Hall, A Aithal, ... Cancer and Metastasis Reviews 38, 223-236, 2019 | 232 | 2019 |
| MUC16 as a novel target for cancer therapy A Aithal, S Rauth, P Kshirsagar, A Shah, I Lakshmanan, WM Junker, ... Expert opinion on therapeutic targets 22 (8), 675-686, 2018 | 223 | 2018 |
| A combination of MUC5AC and CA19-9 improves the diagnosis of pancreatic cancer: a multicenter study S Kaur, LM Smith, A Patel, M Menning, DC Watley, SS Malik, SR Krishn, ... Official journal of the American College of Gastroenterology| ACG 112 (1 …, 2017 | 154 | 2017 |
| Emerging trends in the immunotherapy of pancreatic cancer K Banerjee, S Kumar, KA Ross, S Gautam, B Poelaert, MW Nasser, ... Cancer letters 417, 35-46, 2018 | 113 | 2018 |
| Modeling pancreatic cancer in mice for experimental therapeutics K Mallya, SK Gautam, A Aithal, SK Batra, M Jain Biochimica et Biophysica Acta (BBA)-Reviews on Cancer 1876 (1), 188554, 2021 | 63 | 2021 |
| DNA promoter methylation-dependent transcription of the double C2-like domain β (DOC2B) gene regulates tumor growth in human cervical cancer SP Kabekkodu, S Bhat, R Radhakrishnan, A Aithal, R Mascarenhas, ... Journal of Biological Chemistry 289 (15), 10637-10649, 2014 | 47 | 2014 |
| The current landscape of antibody-based therapies in solid malignancies A Shah, S Rauth, A Aithal, S Kaur, K Ganguly, C Orzechowski, ... Theranostics 11 (3), 1493, 2021 | 37 | 2021 |
| Polyanhydride nanoparticles stabilize pancreatic cancer antigen MUC4β L Liu, P Kshirsagar, J Christiansen, SK Gautam, A Aithal, M Gulati, ... Journal of Biomedical Materials Research Part A 109 (6), 893-902, 2021 | 34 | 2021 |
| Development and characterization of carboxy-terminus specific monoclonal antibodies for understanding MUC16 cleavage in human ovarian cancer A Aithal, WM Junker, P Kshirsagar, S Das, S Kaur, C Orzechowski, ... PloS one 13 (4), e0193907, 2018 | 27 | 2018 |
| Mucins as potential biomarkers for early detection of cancer SK Gautam, P Khan, G Natarajan, P Atri, A Aithal, AK Ganti, SK Batra, ... Cancers 15 (6), 1640, 2023 | 20 | 2023 |
| Regulation of pancreatic cancer therapy resistance by chemokines SK Gautam, S Basu, A Aithal, NV Dwivedi, M Gulati, M Jain Seminars in cancer biology 86, 69-80, 2022 | 17 | 2022 |
| PolysacDB: a database of microbial polysaccharide antigens and their antibodies A Aithal, A Sharma, S Joshi, GPS Raghava, GC Varshney PLoS One 7 (4), e34613, 2012 | 15 | 2012 |
| Chimeric antibody targeting unique epitope on onco-mucin16 reduces tumor burden in pancreatic and lung malignancies A Shah, S Chaudhary, I Lakshmanan, A Aithal, SG Kisling, C Sorrell, ... NPJ Precision Oncology 7 (1), 74, 2023 | 11 | 2023 |
| Muc4 loss mitigates epidermal growth factor receptor activity essential for PDAC tumorigenesis R Bhatia, JA Siddiqui, K Ganguly, CM Thompson, A Cannon, A Aithal, ... Oncogene 42 (10), 759-770, 2023 | 11 | 2023 |
| Endothelin-axis antagonism enhances tumor perfusion in pancreatic cancer SK Gautam, V Dalal, BR Sajja, S Gupta, M Gulati, NV Dwivedi, A Aithal, ... Cancer letters 544, 215801, 2022 | 6 | 2022 |
| Characterization of recombinant β subunit of human MUC4 mucin (rMUC4β) PG Kshirsagar, M Gulati, WM Junker, A Aithal, G Spagnol, S Das, ... Scientific reports 11 (1), 23730, 2021 | 5 | 2021 |
| Targeting MUC4 in pancreatic cancer using non-shed cell surface bound antigenic epitopes A Aithal, C Orzechowski, WM Junker, P Kshirsagar, A Shah, SK Gautam, ... Pancreas 48 (10), 1401-1402, 2019 | 3 | 2019 |
| Muc4 nanovaccine and checkpoint blockade based combination immunotherapy for pancreatic cancer K Banerjee, S Gautam, WM Nasser, P Kshirsagar, K Ross, G Spagnol, ... Cancer Research 77 (13_Supplement), 3678-3678, 2017 | 3 | 2017 |
| MUC4 interacts and stabilize EGFR1 in a ligand‐dependent manner leading to sustained oncogenic signaling R Bhatia, S Joshi, A Aithal, W Junker, C Orzechowski, A Cannon, ... The FASEB Journal 33 (S1), 631.3-631.3, 2019 | 1 | 2019 |
| DNA Methylation Changes in Clinical Stages of Oral Cancer Progression and Correlation with DOC2B Promoter Hypermethylation R Radhakrishnan, U Raghavendra, A Aithal, S Prasada, S Bhat, ... Molecular Cancer Biology, 1-13, 2013 | 1 | 2013 |
